Term Gallery logo

Significats de huntington disease en anglès

rus
болезнь хантингтона
portuguès
coréia de huntington
espanyol
mal de huntington
català
síndrome de huntington
Wikidata

Rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia.

Veure'n més
Termes relacionats
síndrome de huntington
Ús de huntington disease en anglès
1
Whether Huntington disease is responsible for the abnormally low bispectral index remains uncertain.
Pubmed
2
Despite recent important discoveries, the pathogenesis of Huntington disease is still not elucidated.
Pubmed
3
An expansion of a trinucleotide CAG repeat on chromosome 4 causes Huntington disease.
Pubmed
4
Our data provide proof-of-principle for the potential of inducing autophagy to treat Huntington disease.
Pubmed
5
Jean Fleming from the Otago School of Medicine discusses the genetic disorder Huntington Disease.
Radio NZ
6
The involvement of MT 1 receptors in Alzheimer's and Huntington diseases has also been proposed.
Pubmed
7
Huntington disease is one of nine inherited neurodegenerative disorders caused by a polyglutamine tract expansion.
Pubmed
8
Predictive testing follows the Huntington disease protocol.
Pubmed
9
These properties have shown promise in the treatment of conditions such as rheumatoid arthritis, Huntington disease, and multiple sclerosis.
Pubmed
10
Teva Pharmaceutical Industries Ltd's drug, SD-809, is also in late-stage development to treat involuntary movements associated with Huntington disease.
Reuters
11
Several markers closer to Huntington disease have since been isolated, but these all appear to be proximal to the defect.
Pubmed
12
Appropriate nursing-care strategies depend on the early recognition of Huntington disease (HD) to prioritize a plan of care.
Pubmed
13
Phosphorylation of this residue has been implicated in Huntington disease, but the mechanism by which Ser-175 phosphorylation affects transport is unclear.
Pubmed
14
Huntington disease (HD) is most prevalent among populations of western European descent and isolated populations where founder effects may operate.
Pubmed
15
We conclude that bilateral selective excitotoxic lesions of the posterior putamen provide an improved model of the movement disorder of Huntington disease.
Pubmed
16
Aberrant activation of caspase-6 has recently emerged as a major contributor to the pathogeneses of neurodegenerative disorders such as Alzheimer's and Huntington disease.
Pubmed